Tag: PREVAIL trial

#VisualAbstract: Continued enzalutamide after progression of metastatic prostate cancer improves progression-free survival

byMinjee Kim

October 26, 2022

1. The median progression-free survival was higher in the enzalutamide vs the placebo group (9.5 months vs 8.3 months) 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Significant body weight reduction with cagrilintide-semaglutide therapy
Machine learning models diagnose celiac disease at similar performance levels to pathologists
Presymptomatic treatment of spinal muscular atrophy with risdiplam leads to improved functional outcomes

No Result

View All Result